PRIMARY STUDY
Therapeutic potential of cannabidivarin for epilepsy and autism spectrum disorder
Key Findings: This review helps to summarize the current literature regarding the use of cannabidivarin (CBDV), and propyl analog of cannabidiol (CBD), in the treatment of autism spectrum disorders and epilepsy.
Type of Study: Meta-analysis
Study Result: Inconclusive
Study Location(s): Italy
Year of Pub: 2021
Cannabinoids Studied: Cannabidiol (CBD), Cannabinoid (unspecified), Cannabidivarin (CBDV)
Phytocannabinoid Source: Unspecified
